Terminal 14q32.33 deletion as a novel cause of agammaglobulinemia
- 1 October 2017
- journal article
- case report
- Published by Elsevier in Clinical Immunology
- Vol. 183, 41-45
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Primary antibody deficienciesNature Reviews Immunology, 2013
- The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human diseaseGenes & Immunity, 2012
- A child with an inherited 0.31 Mb microdeletion of chromosome 14q32.33: Further delineation of a critical region for the 14q32 deletion syndromeAmerican Journal of Medical Genetics Part A, 2012
- A clinical report and further delineation of the 14q32 deletion syndromeClinical Dysmorphology, 2011
- A deletion 13q34/duplication 14q32.2-14q32.33 syndrome diagnosed 50 years after neonatal presentation as infantile hypercalcemiaAmerican Journal of Medical Genetics Part A, 2011
- Pathogenesis, Diagnosis, and Management of Primary Antibody Deficiencies and InfectionsClinical Microbiology Reviews, 2009
- The ring 14 syndrome: Clinical and molecular definitionAmerican Journal of Medical Genetics Part A, 2009
- Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemiaMolecular Immunology, 2007
- Terminal 14q32.33 deletion: Genotype–phenotype correlationAmerican Journal of Medical Genetics Part A, 2006
- Molecular basis of IgG subclass deficiencyImmunological Reviews, 2000